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Objectives: Meningococcal meningitis (MM) is still a huge threat in the African meningitis belt. To
fight against epidemics, a strengthened health information system, based upon weekly collected
data, was set up in Mali. We aimed to study the spatio-temporal dynamics of MM in this country
between 1992 and 2003.
Methods: Wewere first interested in the impact of population size on the disease persistence. We
then used cross-correlation analysis to study the spread of the disease on three different spatial
scales, i.e., inter-region (global) and inter-district and intra-district (local) levels.
Results: WefoundnopersistenceofMMatdistrict level inMali during thewholeof the studyperiod.
However, we found persistence on a nationwide scale after the 1997 big epidemics, as opposed to
the1992—1996 timeperiods. In termsof spread, twomain regions seemto leadMMdynamics inMali,
even if on a local scale the ‘cities—villages’ diffusion pattern was not systematically observed.
Conclusions: This study improves knowledge on the spread and persistence of MM in Mali in recent
years. It constitutes a first spatial study describing persistence and spread of MM in an African
meningitis belt country. The next step should be the integration of vaccination and genetic
variability data to clarify the route of spread of the disease in the human population.
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Neisseria meningitidis, causing meningococcal meningitis
(MM), is a strictly human bacterium, transmitted from person
to person by oral and tracheobronchial secretions.1 A large
proportion (10—25%, according to the World Health Organi-
zation (WHO)) of a population can be asymptomatic carriers
in endemic times, and there is no animal reservoir.2 In West
Africa this highly infectious disease is very seasonal, appear-
ing in the dry season between December and June, fading out
each year with the first rainfall of the African monsoon.3
Typically, other infectious agents responsible for meningitis
do not have the same seasonality. The physiopathologic
hypothesis is a seasonal inflammation of the nasopharyngeal
sphere, caused by dry and dusty Harmattan winds, whichFigure 1 Administrativecreates a seasonally reinforced possibility for N. meningitidis
to cross the nasopharyngeal barrier and contaminate the
bloodstream and the brain. A recent work has shown how
much the onset of meningitis epidemics in Mali is strongly
correlated with a ‘winter maximum’, whose average week is
the 6th of the calendar year.4 Beyond strong seasonality of
annual MM cases, larger MM epidemics also occur every 8 to
12 years.5
Many serogroups of N. meningitidis are known, but the
most prevalent are serogroups A and C.6 Moreover, the
spread of serogroup W135 in sub-Saharan Africa since the
years 2000—2001 is a growing threat.7—9 Serogroup A was
the main cause of the great epidemics of the meningitis
belt3 in sub-Saharan Africa until the end of the 20th
century. This area, from Senegal to Ethiopia, recordedunits (districts) in Mali.
Figure 3 Meningitis spread between administrative regions in
Mali from 1996 to 2003.
Figure 2 (A) Mean number of fade-outs by year and (B) mean
duration of a fade-out in weeks, in relation to the population
size, in 48 districts of Mali from 1992 to 2003. A fade-out is
defined as at least 2 weeks with no new cases in the locality.
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more than 200 000 cases and more than 20 000 deaths.
In Mali, the maximum was reported in 1997 with more than
11 000 cases.
At a local level, it is important to understand how the
disease spreads within the human population. A new field in
epidemiology, combined with ecology, studies the impact of
population size and flux on persistence and spread of infec-
tious diseases. These issues have already been studied for
two other vaccine-preventable diseases, pertussis and
measles.10—14 In a metropolitan analysis, these studies used
the concept of ‘critical community size’ (CCS) initially devel-
oped by Bartlett.15 This argues that the local persistence of a
disease may be possible without any reintroduction from
outside of the community if a population size threshold is
achieved. If case reporting does not show any fade-out for a
given population, it means that this community can behave
like a reservoir for the disease. Such a fact may influence
surveillance and vaccination strategies. It also contributes to
a better understanding of both the global and local dynamics
of the disease.
In the ‘cities—villages’ concept presented by Anderson
and May,16 infectious disease transmission progresses from
urban places (‘cities’) to the countryside (‘villages’). Such a
result, if validated, could imply the identification of a recur-
rent source of infection and thus allow a targeted control by
vaccination.
With these kinds of approaches, we aimed to study the
spatio-temporal dynamics of MM in Mali between 1992 and
2003. We first focused on the impact of population size on
persistence of the disease. We then studied the spread of the
disease on three different spatial scales. We compared MM
dynamics (1) across the eight administrative regions and (2)
the many different districts that represent the administra-
tive level of the district health systems. Finally, (3) we
investigated MM spread within each district, testing the
city—village concept. This double approach of persistence
and spread of the disease provides new insights into both MM
epidemic dynamics and control debates.
Methods
Epidemiological data
The WHO has defined three kinds of meningitis case in Africa.
A ‘suspected case’ is a clinically based one. A ‘probable case’
is either a suspected case viewed in an epidemic context, or a
suspected case with a cloudy cerebrospinal fluid. A ‘case’ is
confirmed when the etiology is biologically established. In
Mali and other Sahelo-Sahelian countries, most of the
reported cases are just suspected ones, because few health
centers are able to achieve a lumbar puncture, which would
be the first step to diagnosis. However, the symptoms of
acute meningitis like fever, photophobia, and stiff neck, are
really well known and specific enough.
For our analysis, we collected the suspected cases
reported weekly in each district (see Figure 1) by locality
from 1992 to 2003 by the strengthened meningitis surveil-
lance system in Mali. This warning system is based upon
weekly reporting from each health center, including zero
case reporting.17 District population numbers were extracted
from the 1998 national population census.18Persistence and population size
The WHO states that the average incubation time is around 4
days (range 2—10 days), and the French health authorities
recommenda treatment timeof 7—10days.Hence,wedefined
Figure 4 (A) Auto- and cross-correlation between the time series of Bamako termed ‘urban’ and the sum of cases in all other localities
termed ‘rural’ from 1996 to 2000. The top left and bottom right graphs illustrate autocorrelation patterns at a weekly lag for rural and
urban time series, respectively. The off diagonal graphs showcross-correlation between the two specified time series. The top right shows
positive weekly lags (leads) for urban cases; the bottom left, negative weekly lags. Dashed lines indicate 95% approximate confidence
intervals for no correlation. (B) Map of time-lags in weeks between Bamako time series and each other district time series computed by
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case in a given locality. We also tested the three-week period
threshold, which gave similar results (not shown).
After a survey of missing values in the Malian districts for
the cases reported between 1992 and 2003, wewere left with
48 districts. We transformed each series into binary formwith
‘1’ when one case or more was reported and ‘0’ in the case of
the zero case indication. Missing values were transformed
into ‘1’ in order not to exaggerate the fade-out effect. At the
beginning of each time series, a ‘1’ was generated as a
starting point to the analysis of fade-out. We calculated
the number of fade-outs and their duration and plotted
the results as a function of population size.
Spread of the disease: a multi-spatial scales
approach
We studied the MM spread on three different spatial scales,
i.e., at regional, inter-district, and intra-district level, per-
forming cross-correlations between time series of MM cases.
Cross-correlation consists of the calculation of a standard
correlation between two time series at different time-lags.
We computed all our analyses with S-plus Software.
On the regional scale, we were able to compute time
series running from 1996 to 2003 for seven of the eight
regions of Mali.
We then focused on the inter-district scale. We sought to
determine if any district was systematically in advance of the
others between 1996 and 2000. After regional scale results,
we were mainly interested in Bamako as a potential source of
the disease, because this city, which with a population of one
million people is the only large city in Mali, represents both
the most densely populated area of Mali and the biggest
community size in this very rural country. We made all pair-
comparisons and built up a synthetic map with the software
ESRI1 ArcMap 8.3.
Finally, inside each district, we decided to test the
‘cities—villages’ framework by classifying the chief-town
as ‘city’ (urban) and the other localities as ‘villages’ (rural).
Indeed, the chief-town of each district, which contains the
district authorities and services and is the district’s epon-
ymous locality, often has a real urban part, in contrast with
villages or so-called other localities. For each district we
generated two time series, one termed ‘urban’, correspond-
ing to time series of MM cases of the chief-town, and the
other termed ‘rural’, constituted of the sum of cases in all
other localities of the district. However, since all chief-towns
do not necessarily represent the most populated locality in
the district, we performed similar analyses defining as
‘urban’ the most populated locality. We computed cross-
correlation analyses and built up synthetic maps.
Results
Persistence of meningitis
Themean number of fade-outs by year and themean duration
of a fade-out in relation to the population size for the 48cross-correlation analyses between 1996 and 2000. A positive time-la
advance means a lead from the other district.districts investigated are shown in Figure 2A and Figure 2B,
respectively. There was no persistence of MM at the district
level during the period 1992—2003. Even Bamako experi-
enced several fade-outs each year. The number of fade-outs
by year and the duration of these fade-outs are dependent on
population size. The district of Bamako had the least number
and duration of fade-outs. The framework of critical com-
munity size in metapopulation biology is thus achieved with
meningitis in Mali, but without reaching any sufficient com-
munity size for local persistence by district. The district of
Bamako had the least number and duration of fade-outs, and
it experienced a mean duration of a fade-out of around 8
weeks each year (Figure 2B).
Spread of meningitis
At the regional level, Koulikoro region (including the city of
Bamako) and Mopti region were synchronous, but Mopti was
the only one to have an advance of one week on the south and
west (Kayes, Sikasso, Segou). Koulikoro region appeared at 5
and 4 weeks earlier than Gao and Timbuktu regions, respec-
tively. On the other hand, the region of Kayes seemed to be in
advance of Sikasso region (2 weeks), and Mopti region was
only 2 weeks in advance of the north (Timbuktu and Gao
regions). These results on a regional scale introduce the
hypothesis of a global spread from the west and south to
the north of Mali, with a big synchronism between the regions
of Kayes, Koulikoro, and Segou and a special role played by
the region of Mopti as well as the city of Bamako. Results are
summarized in Figure 3.
At inter-district level, we found that the district of
Bamako was in advance of all other districts for one week
between 1996 and 2000 (Figure 4A). This global result was
confirmed by a detailed pair-wise analysis summarized in a
map (Figure 4B). This map shows several rings around
Bamako, whose time-lag becomes longer from Bamako’s
neighboring districts towards districts at the periphery of
the country. However, two districts are in advance of
Bamako: Kangaba and San. This may be due to the fact there
was not one but several ‘sources’ of MM in Mali between 1996
and 2000, in accordance with the absence of any local
persistence of the disease.
Finally, inside each district, we found three kinds of
spread: (1) the chief-town in advance of the remainder of
the localities (rural) in 14 districts, (2) the chief-town in
delay with the remainder of the localities in 17 districts, and
(3) a synchronism between time series in five districts. This
emphasizes the great variety of situations observed in Mali.
Results obtained for each district are summarized on a map
(Figure 5A). When defining the urban time series as the most
populated locality (Figure 5B), we obtained the opposite
pattern with, in most cases (15 districts), the ‘urban’ time
series in advance of the ‘rural’ ones, making more relevant
the definition of ‘urban’ as the most populated locality. This
result needs to be put into context with the contrasting
population distribution in Mali. Indeed, during the period
under scrutiny, 1996—2000, districts with an internal spread
from the chief-town or from the most populated locality are
mainly situated in the north of the country (very low popula-g represents an advance of Bamako. On the contrary, a negative
Figure 5 (A) Map describing the time-lag between the chief-town (termed ‘urban’) and the sum of the remaining locality cases
(termed ‘rural’) computed by cross-correlation from 1996 to 2000. A positive time-lag means an advance of the chief-town time series.
(B) Same as (A) with ‘urban’ defined as the most populated locality time series.
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part of Mali (higher population density) in terms of absolute
number of cases, so that districts with an internal ‘city—
villages’ spread have a rather scattered population.
Discussion
In this study, we did not observe persistence of MM at district
level in Mali. Indeed, there are a lot of periods of disappear-
ance of the disease on this spatial scale. This result is also
confirmed on a broader scale from 1992 to 1995 by consider-
ing the whole country together. However, this lack of persis-
tence contrasts strongly with the next period. In 1996, there
was only one two-week fade-out. And after 1997, there was
no fade-out, with never more than one week without any
case in the entire country (results not shown). Moreover, this
nationwide persistence from 1997 to 2003 was not induced by
a local one; even Bamako, the most populated district,
experienced several fade-outs each year from 1997 to
2003. This could be explained by a potential increase in
the number of asymptomatic carriers after the big epidemics
in 1997, probably representing a big reservoir of the disease,
helping to maintain its global persistence even in inter-
epidemic periods. Further investigations are needed to spe-
cify if this global persistence after 1997 represents a real
change in the disease spatial dynamics in Mali or if it is drawn
from the better epidemiological surveillance. Indeed, after
the great 1996—1997 epidemics, a specific international out-
lay on seasonal meningitis was promoted by the WHO to
improve disease surveillance and response.
Our analysis of spread at a national level showed that
Bamako might not be the unique source of the disease for the
whole country, since the Mopti region seems to also act as a
potential source. Taking into account that Sikasso region
leads only 1 week before Timbuktu, we may suppose that
there is an effective spread from the south towards the northof the country. The successive steps may be, first the city of
Bamako and Mopti region, then southern and western parts of
the country, then the north part following the big axes of
communication: the Niger River and the road from Bamako to
Gao through Mopti. It is relevant because Bamako is the
largest city in Mali, the most densely populated area of
the country and Mali’s bridgehead towards the rest of the
country. It is also relevant for Mopti, which is very close to
Burkina Faso in terms of neighboring and of exchange inten-
sity, and represents one of the poorest areas in Mali. Further-
more, on a national scale, the 1-week advance of Bamako’s
district on all the others appears very weak, in contrast with
other diseases.19
After the big epidemics in 1996 and 1997, we can consider
that a lot of people had acquired an immunity induced by
infection, carriage, or vaccination, since reactive vaccina-
tion was performed, as recommended by the WHO,20 at
different times following the wave of the epidemic. The
short advance of Bamako during the years 1996—2000 may
correspond, in these conditions, to a spatio-temporal hetero-
geneity in disease dynamics due to the contrasting immune
statuses of the population. The next step should be studies
into the other dynamics and spatial spread of MM, including
serogroup and clonal complex information when available.
How do epidemics due to one serogroup interfere with the
dynamics of another serogroup? This question is of great
interest with regard to vaccination strategies in the long-
term, which are permanently under debate.20—26
Conclusions
The spatio-temporal dynamics of MM show heterogeneous
patterns in Mali during the timer period 1992—2003. There
was no MM persistence of the disease at a district level during
the whole period. Inside each district, we showed the spread
of the disease from city to villages as well as from villages to
Meningococcal meningitis in Mali 109city. This heterogeneity can be explained by many factors,
including immunity status of the population as well as both
socio-demographic and climatic conditions, which are very
different in the north and south of Mali. The next step in this
study should be the integration of vaccination and serogroup
data27,28 in order to clarify the main spatial pattern of MM
spread on different scales. The challenge is now (1) to under-
stand the disease spread in order to clearly identify the
potential source and (2) to understand the interference
between serogroups circulating in the same population.
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